Lancet Publishes Data from Bharat Biotech’s Phase 1 Trial, Developers Hail Move
Putting to rest concerns raised after its emergency approval earlier this month, the Lancet Infectious Disease journal published a study that said Covaxin – India’s first indigenous vaccine against Covid-19 – showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials. The study comes at a time … Read more Lancet Publishes Data from Bharat Biotech’s Phase 1 Trial, Developers Hail Move